Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. ('Repare' or the 'Company') (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the acceptance of four abstracts for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, Illinois.
Mini-Oral Presentation Details:
Title: Efficacy and safety of the combination PKMYT1-inhibitor lunresertib and ATR-inhibitor camonsertib in patients with ovarian and endometrial cancers: Phase I MYTHIC study (NCT04855656)
Presenter: Alison M. Schram, MD, Memorial Sloan Kettering Cancer Center
Session: Innovative Approaches to Key Molecular Targets
Session Date and Time: Tuesday, April 29 from 2:30-4:30 p.m. CT
Location: Room S406 (Vista Ballroom)
Abstract Number: CT262
Title: The PLK4 inhibitor RP-1664 drives centriole modulation and single agent tumor regressions in preclinical neuroblastoma models
Presenter: John M. Maris, MD, Children's Hospital of Philadelphia
Session: Advancing the Science of Childhood Cancers: From Bench to Bedside
Session Date and Time: Sunday, April 27 from 3:00-5:00 p.m. CT
Location: Room E353 C
Abstract Number: 1201
Poster Presentation Details:
Title: A dual mechanism of sensitivity to PLK4 inhibition by RP-1664 in neuroblastoma
Presenter: Michal Zimmermann, PhD, Repare Therapeutics
Session: Cell Cycle Effects of Anticancer Drugs
Session Date and Time: Sunday, April 27 from 2:00-5:00 p.m. CT
Location: Poster Section 17
Poster Number: 9
Abstract Number: 365
Title: RP-1664: A potent and selective PLK4 inhibitor causing tumor regressions in TRIM37-high xenograft models of solid tumors
Presenter: Anne Roulston, PhD, Repare Therapeutics
Session: Kinase and Phosphatase Inhibitors 1
Session Date and Time: Monday, April 28 from 9:00 a.m-12:00 p.m. CT
Location: Poster Section 21
Poster Number: 9
Abstract Number: 1734
Title: Pan-cancer analysis of TRIM37 copy-number and development of fit-for-screening in situ hybridization tools
Presenter: Isabel Soria-Bretones, PhD, Repare Therapeutics
Session: Diagnostic Biomarkers 2
Session Date and Time: Sunday, April 27 from 2:00-5:00 p.m. CT
Location: Poster Section 31
Poster Number: 2
Abstract Number: 717
Title: Targeting CCNE1 amplification in gastric cancer
Presenter: Sung Joo Jang, Columbia University Irving Medical Center
Session: Protein Kinases and Phosphatases as Targets for Therapy
Session Date and Time: Wednesday, April 30 from 9:00 a.m.-12:00 p.m. CT
Location: Poster Section 24
Poster Number: 4
Abstract Number: 6942
A copy of each poster presentation is available on the Scientific Resources page of the Repare Therapeutics website and a copy of each mini-oral presentation will be available on the Scientific Resources page of the Repare Therapeutics website at the start of each mini-oral session.
About Repare Therapeutics Inc.
Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx ® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company's clinical-stage pipeline includes RP-1664, a Phase 1 PLK4 inhibitor; RP-3467, a Phase 1 Polθ ATPase inhibitor; and lunresertib, a PKMYT1 inhibitor. For more information, please visit www.reparerx.com and follow @Reparerx on X (formerly Twitter) and LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Playing A Hot Hand--75% Of S&P 500 Companies Reporting Earnings Last Quarter Exceeded Their Earnings Expectations
With all the talk of wild card "X" factors such as President Donald Trump's tariffs or instability in the Middle East, unsettling the stock market, you would logically expect the quarterly earnings season to be full of bad news. It is impossible to deny that the last quarter was a roller coaster ride for investors. However, it may surprise you to learn that over 75% of the S&P 500 exceeded their earnings expectations in their most recent quarterly report. According to public filing data compiled by FactSet, 374 out of the 481 companies that released reports exceeded their per-share earnings expectations. By contrast, only 19 companies reported EPS "in line" with expectations, while 88 fell short. The revenue picture was a bit more evenly weighted but still offered solid wins for investors. Some 305 companies beat revenue expectations, while 175 fell short of the mark. Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can The overwhelmingly positive performance means businesses in almost every sector successfully adjusted to market instability and thrived. It's certainly good news for investors and analysts, who will collectively hope that the strong quarter is a sign that things may be returning to normal on Wall Street. The recent announcement that Trump and Chinese President Xi Jinping have reached a tentative truce may go even further to calm the nerves of anxious investors. With that said, some companies scored huge quarterly wins by radically outperforming consensus EPS expectations. According to FactSet, the biggest winner was Intel (NASDAQ: INTC), which exceeded EPS expectations by nearly 2,000%. The chipmaker announced EPS of $0.13, which was a massive improvement on the $0.01 that analysts had predicted. Intel's $12.67 billion in revenue also beat the consensus analyst predictions of $12.30 billion by 2.98%. The next biggest winner on the EPS list was Carnival (NYSE: CCL), with $0.13. According to Benzinga, the consensus analyst expectations for Carnival were around $0.02. Carnival's performance was good enough to beat expectations by 550%. The cruise giant has a "Buy Now" rating from Stifel and Citigroup, which both recently raised their price expectations. Citi moved from $31 to $33, while Stifel went from $25 to $28. Trending: Maximize saving for your retirement and cut down on taxes: . Travelers (NYSE: TRV) also posted a strong quarter with EPS of $1.91, which was good enough for third place on FactSet's list of biggest EPS surprises. Travelers' $11.81 billion in revenue also bested the prognosticators' $10.81 billion by 9.25%. Passive income investors might also like Travelers' 1.76% dividend, which translates to roughly $4.40 per share based on the current price of $262.02. The remaining seven best performers on FactSet's top 10 EPS surprises are: GE Vernova (NYSE: GEV) +129.2% Valero Energy Corp. (NYSE: VLO) +116.9% Estee Lauder Cos. Class A (NYSE: EL) +107.9% Weyerhaeuser (NYSE: WY) +100% Nike (NYSE: NKE) Class B +79.6% Deckers Outdoor (NYSE: DECK) +65.5% Uber Technologies (NYSE: UBER) +63.5% Taken as a whole, it's a very diverse list of companies operating across multiple sectors of the economy. To see the S&P 500 performing so strongly despite the recent headwinds is an encouraging sign. Read Next: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Can you guess how many retire with a $5,000,000 nest egg? . Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Playing A Hot Hand--75% Of S&P 500 Companies Reporting Earnings Last Quarter Exceeded Their Earnings Expectations originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
Origin Agritech to Hold Business Update & First Half of Fiscal Year 2025 Earnings Conference Call on Friday, June 27th at 8 a.m. ET
BEIJING, June 23, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, will announce its financial results for the first half of fiscal year 2025 on Thursday, June 26th after the market closes. Origin will host a conference call on Friday, June 27th at 8 a.m. ET with the investment community to discuss the Company's financial results and provide a business update. CONFERENCE CALL & AUDIO WEBCAST The conference call will be led by Mr. Weibin Yan, Chief Executive Officer, and Mr. Patrick Cheng, Chief Financial Officer, who will be available to answer questions. Investors may submit written questions by June 25th via e-mail to matthew@ To access the call by phone, please call 1-800-225-9448 (United States) or 1-203-518-9708 (International) using the conference ID: ORIGIN. To avoid delays, we encourage participants to dial into the conference call 15 minutes before the scheduled start time. The webcast can be accessed at the following link: A webcast replay will be available for two weeks. About Origin Agritech Limited Origin Agritech Limited, founded in 1997 and headquartered in Origin R&D Center, Songzhuang, Tongzhou in Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnologies, Origin Agritech's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and pest resistance (Bt) traits. For further information, please visit the Company's website at The Company also maintains an X account for updating investors on Company and industry developments which is For more information, please contact:Origin Agritech Limited Contact:Kate Lang (Mandarin/English)Director of Investor RelationsPhone: +86 186-1839-3368E-mail: Investor Relations Contact:Matthew Abenante, IRCPresidentStrategic Investor Relations, LLCTel: 347-947-2093E-mail: matthew@ View original content: SOURCE Origin Agritech Limited
Yahoo
14 minutes ago
- Yahoo
European Commission Approves Liberty Media's Acquisition of MotoGP™
ENGLEWOOD, Colo., June 23, 2025--(BUSINESS WIRE)--Liberty Media Corporation ("Liberty Media") (Nasdaq: FWONA, FWONK, LLYVA, LLYVK) received unconditional approval today from the European Commission to complete its acquisition of Dorna Sports, S.L. ("Dorna"), the exclusive commercial rights holder of the MotoGP™ World Championship ("MotoGP"). Receipt of the European Commission's approval is the final condition to the transaction, which is now expected to close no later than July 3, 2025. This acquisition enables Liberty Media to accelerate MotoGP's international appeal and bring captivating racing to a wider global audience. The first MotoGP season was held in 1949 with six rounds staged across Europe and has grown to comprise 22 races across 18 countries for the 2025 season, which is broadcast to hundreds of millions internationally. Liberty Media will leverage its expertise in developing sports and entertainment assets to further expand MotoGP's fanbase and grow the sport commercially. Carmelo Ezpeleta, CEO of Dorna since 1998, will continue to run the business headquartered in Madrid. "Today's approval from the European Commission marks the final condition to closing Liberty's acquisition of MotoGP. We are thrilled to officially commence Liberty's partnership with Carmelo and his excellent management team," said Derek Chang, Liberty Media President and CEO. "MotoGP is a highly attractive premium sports asset with incredible racing, a passionate fanbase and a strong cash flow profile. We believe the sport and brand have significant growth potential, which we will look to realize through deepening the connection with the core fan base and expanding to a wider global audience." "We are very happy that the European Commission has approved the transaction. This is an important milestone confirming the even brighter future that lies ahead for MotoGP," said Carmelo Ezpeleta, CEO of MotoGP rights holder Dorna. "MotoGP is one of the most thrilling sports on earth, and we look forward to accelerating the sport's growth and expanding its reach to even more fans around the world. Liberty is the best possible partner for our sport and the entire MotoGP community, and we are excited to create even greater value for our fans, commercial partners and everyone competing." Liberty Media will acquire 84% of Dorna with Dorna management retaining 16% of the business. The transaction reflects an enterprise value for Dorna of €4.3 billion1 and an equity value of €3.7 billion with the existing debt balance at Dorna expected to remain in place after closing. The purchase price for Liberty Media's 84% stake will be paid in cash, including cash on hand at Formula One Group and Formula 1 and proceeds from $1 billion of committed term loan financing at Formula 1. Formula 1's pro forma net leverage following the acquisition is expected to be under 3.5x, which would permanently reduce the margin on F1's Term Loan B to 1.75%. Promptly after the transaction closes, Formula One Group expects to draw from Dorna cash and committed term loan proceeds, bringing pro forma leverage at Dorna to just below 5.5x. Following the transaction close, members of Liberty Media's board of directors and management team, including Chase Carey, director of Liberty Media and former CEO of Formula 1, and Sean Bratches, former Managing Director of Commercial Operations at Formula 1, will join Carmelo Ezpeleta and Enrique Aldama, the Chief Operating and Financial Officer of Dorna, on Dorna's board of directors, which is responsible for oversight of the business and its strategic direction. Liberty Media has received the necessary regulatory approvals in all other jurisdictions to close the acquisition. Following the acquisition, Liberty Media's Formula One Group tracking stock will be comprised of its subsidiaries Formula 1, MotoGP and Quint, as well as certain minority investments. About Liberty Media Corporation Liberty Media Corporation operates and owns interests in media, sports and entertainment businesses. Those businesses are attributed to two tracking stock groups: the Formula One Group and the Liberty Live Group. The businesses and assets attributed to the Formula One Group (NASDAQ: FWONA, FWONK) include Liberty Media's subsidiaries Formula 1 and Quint, and other minority investments. The businesses and assets attributed to the Liberty Live Group (NASDAQ: LLYVA, LLYVK) include Liberty Media's interest in Live Nation and other minority investments. About Dorna Sports, S.L. & MotoGP™ Dorna Sports became the sole commercial and television rights holder of the FIM MotoGP™ World Championship in 1991 and is based in Madrid, with premises in Barcelona and a subsidiary in Rome. Dorna holds exclusive rights to MotoGP feeder series Moto2™ and Moto3™, electric series MotoE™, the FIM Superbike World Championship and the FIM Women's Circuit Racing World Championship. Cautionary Note Regarding Forward-Looking Statements This press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including certain statements relating to the proposed transaction, the timing of its completion, statements relating to our expectations regarding Dorna and its MotoGP business and prospects and matters relating to debt. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws. These forward-looking statements generally can be identified by phrases such as "possible," "potential," "intends" or "expects" or other words or phrases of similar import or future or conditional verbs such as "will," "may," "might," "should," "would," "could," or similar variations. These forward-looking statements involve many risks and uncertainties that could cause actual results and the timing of events to differ materially from those expressed or implied by such statements, including, but not limited to: historical financial information may not be representative of future results; there may be significant transaction costs and integration costs in connection with the proposed transaction; the parties may not realize the potential benefits of the proposed transaction in the near term or at all; the proposed transaction may not be consummated; there may be liabilities that are not known, probable or estimable at this time; the proposed transaction may result in the diversion of management's time and attention to issues relating to the proposed transaction and integration; unfavorable outcome of legal proceedings that may be instituted against the parties; risks inherent to the business may result in additional strategic and operational risks, which may impact Liberty Media's risk profile, which it may not be able to mitigate effectively; and other risks and uncertainties detailed in periodic reports that Liberty Media files with the SEC. These forward-looking statements speak only as of the date of this press release and Liberty Media expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statement contained herein to reflect any change in Liberty Media's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Please refer to the publicly filed documents of Liberty Media, including its most recent Forms 10-K and 10-Q, as such risk factors may be amended, supplemented or superseded from time to time by other reports Liberty Media subsequently file with the SEC, for additional information about Liberty Media and about the risks and uncertainties related to Liberty Media's businesses which may affect the statements made in this press release. (1) Includes €126 million payment to sellers to extend the longstop date for regulatory approval. View source version on Contacts Liberty Media Corporation – Investor Contact Shane Kleinstein, +1 720-875-5432 Dorna Sports, S.L. – Media Contact Frances Wyld, franceswyld@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
